
Xylem (XYL) exceeded Q2 2025 expectations, reporting non-GAAP EPS of $1.26 against a $1.15 consensus and GAAP revenue of $2.3 billion, marking 6.0% year-over-year growth and improved profitability across segments. The company subsequently raised its full-year 2025 revenue and adjusted EPS guidance, signaling confidence in sustained operational momentum driven by broad-based segment growth, productivity gains, and acquisition synergies, despite management noting potential for future order volatility and margin pressures from business mix.
Xylem (XYL) reported a strong second quarter for 2025, surpassing consensus estimates with a non-GAAP EPS of $1.26 against a $1.15 forecast and achieving 6.0% year-over-year GAAP revenue growth to $2.3 billion. The outperformance was driven by broad-based growth across all segments, most notably a 12% revenue increase in Measurement and Control Solutions, highlighting robust demand for smart technology and analytics. Profitability metrics showed significant improvement, with GAAP operating margin expanding by 1.6 percentage points to 13.3% and adjusted EBITDA margin reaching a new high of 21.8%. Management attributed this margin strength to successful pricing actions, productivity gains, and faster-than-expected cost synergies from the Evoqua acquisition. The company's confidence is further underscored by its decision to raise full-year 2025 guidance for both revenue, now projected at $8.9–$9.0 billion, and adjusted EPS, now targeted at $4.70–$4.85. Despite this positive outlook, the company acknowledged specific risks, including near-term margin pressure in the Measurement and Control segment due to an unfavorable sales mix and the potential for order volatility related to pricing and tariffs.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request a DemoOverall Sentiment
strongly positive
Sentiment Score
0.80
Ticker Sentiment